BIOCOM AMR Conference – Investor Year of Action on AMR
On August 27, Mara Lilley, Investor Engagement Manager for the Access to Medicine Foundation, will join BIOCOM's 4th annual AMR Conference virtually to discuss Investor Action on Antimicrobial Resistance (AMR).
The #AMRconference is a platform for small and medium-sized enterprises (SMEs), start-ups, large R&D-based pharmaceutical companies, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. The conference will be held virtually.
Mara Lilley will participate in the panel "Spotlight on UK: Investor Action on AMR", on Thursday, August 27 as part of the day's overarching Financing & Investing theme.
The discussion will be moderated by Louise Norton-Smith, Head of Global Antimicrobial Resistance Strategy & Delivery, UK Department of Health & Social Care.
The keynote speech will be delivered by Dame Sally Davies – UK Special Envoy on Antimicrobial Resistance & former Chief Medical Officer for England.
Other speakers for the panel include:
- Maria Lettini, Executive Director, FAIRR Initiative
- Catherine McCabe, Senior Associate | Analyst | Responsible Investment, BMO Global Asset Management (EMEA)
- Matt Crossman, Stewardship Director, Rathbone Investment Management
The 2020 AMR Conference is hosted virtually by BIOCOM, a Life Science-focused information provider, offering communication services, organising events and publishing European media in the fields of pharma, biotech and bioeconomy. The full programme for the digital AMR Conference can be found here.